Author Topic: Axis Capital 2016 Top Picks  (Read 8119 times)

0 Members and 1 Guest are viewing this topic.

komal

  • Sr. Member
  • ****
  • Posts: 376
Axis Capital 2016 Top Picks
« on: January 05, 2016, 11:27:40 AM »
Aurobindo Pharma Key beneficiary of faster USFDA approvals; turnaround in EU - Target 976
Bajaj Finserv Stake sale in Insurance JV offers scope for re-rating - Target 2142
eclerx Reset for growth in the fragmented industry - Target 1615
Indraprastha Gas Clean Fuel Drive – trigger to volume growth - Target 590
Indian Hume Pipe Government’s initiatives in water segment to drive growth - Target 484
Reliance Industries Reliance-Jio – The Next phase of growth - Target 1140